e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Adult bronchiectasis: risk factors and future perspectives
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles
james hill (Dundee, United Kingdom), James Hill, Duncan Renton, Hani Abo-Leyah, Megan Crichton, Simon Finch, Thomas Fardon, James Chalmers
Source:
International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Session:
Adult bronchiectasis: risk factors and future perspectives
Session type:
Oral Presentation
Number:
466
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
james hill (Dundee, United Kingdom), James Hill, Duncan Renton, Hani Abo-Leyah, Megan Crichton, Simon Finch, Thomas Fardon, James Chalmers. Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles. Eur Respir J 2015; 46: Suppl. 59, 466
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011
Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Microbiological factors of acute attack in patients with bronchiectasis
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Bronchiectasis prevalence and relationship with clinical features in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Microbial aetiology and outcomes of CAP in bronchiectatic patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006
Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Diagnosis and aetiological treatment of bronchiectasis in adult patients
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept